Behind the Study: Predictive miRNA Signature and Breast Cancer
Researchers from the University of Vermont discuss their study, published by Oncotarget in 2017, titled, "... read more
March 29, 2021
Category: Oncotarget
Behind the Study: LINC00520 and Breast Cancer
The Behind the Study series transcribes videos of researchers elaborating on their papers... read more
March 22, 2021
Trending with Impact: Benign, Borderline, and Malignant Breast Tumors
Researchers conducted a 2021 study to better characterize phyllodes tumors and other breast fibroepithelial lesions... read more
March 18, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #6
Read short summaries of the latest research literature published by Oncotarget.Origin: Missouri,... read more
March 16, 2021
Behind the Study: Phenanthrene and Human Pancreatic Cancer Cells
Senior researcher, Professor Malka Cohen-Armon, describes the study she co-authored in Oncotarget entitled, “The phenanthrene... read more
March 15, 2021
Trending With Impact: Hepatocellular Carcinoma in The Andes Mountains
Young people living in the Andes Mountains are disproportionately affected by hepatocellular carcinoma compared to... read more
March 11, 2021
Behind the Study: Melatonin and Prostate Cancer
Professor Vladimir Anisimov details the study he co-authored in an Oncotarget publication, titled: “Melatonin increases... read more
March 11, 2021
Can Precision Oncology Improve Patient Outcomes AND Cut Costs?
In this top-performing paper, researchers compare the overall survival, average total healthcare costs, and resource... read more
March 9, 2021
Behind the Study: New Clues for Targeting Drug Resistant Colon Cancers
Dr. Bruce Boman from the Helen F. Graham Cancer Center describes the findings in a... read more
March 8, 2021
Trending with Impact: Machine Learning Used to Compare ALK Inhibitors
Researchers use a computer simulated modeling system to highlight the strengths and weaknesses of two... read more
March 4, 2021